Management of Mycobacterium Abscessus Infections: The Rise of a Superbug

Infections caused by Mycobacterium abscessus appear to be increasing in frequency among the immunocompromised population and are challenging to treat. Antibiotic options in these cases are scarce, prologued therapy is required and new options are needed. We will discuss this important topic with experts in the field.

Topics discussed:
- Define M. abscessus as an opportunistic pathoge
The intrinsic phenotypic characteristics of M. abscessus, including resistance to common antimicrobials
- Treatment approaches and rationale for these strategies

- Kelly Dooley, MD. PhD, MPH.  Professor of Medicine, Johns Hopkins University and Editor of AAC
- Charles L. Daley, MD, Professor and Chief of the Division of Mycobacterial and Respiratory Infections. National Jewish Health
- Thomas Dick, PhD. Professor, Center for Discovery and Innovation, Hackensack Meridian Health

This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit to sign up

Visit to browse issues and/or submit a manuscript.

Be the first to comment